Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experience


KILIÇ L. , KARADAĞ Ö. , Erden A., SARI A. , ARMAĞAN B. , YARDIMCI G. K. , ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.50, sa.1, ss.31-36, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Konu: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3906/sag-1906-39
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Sayfa Sayıları: ss.31-36

Özet

Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu's arteritis (TA) patients who are unresponsive to corticosteroids +/- conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety of anti-IL-6 (tocilizumab) therapy in refractory TA patients in real life.